Ella Naparstek

The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?

S. Slavin, R. Or, L. Weiss, 1990, Bone marrow transplantation.

Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.

A. Nagler, J. Kapelushnik, S. Slavin, 1995, Experimental hematology.

Lack of known hepatitis virus in hepatitis-associated aplastic anemia and outcome after bone marrow transplantation

A. Nagler, E. Galun, Y. Ilan, 2001, Bone Marrow Transplantation.

T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse

S. Steinberg, A. Nagler, G. Hale, 1995, British journal of haematology.

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.

A. Nagler, A. Chetrit, S. Elad, 1996, Transplantation.

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

A. Nagler, D. Engelhard, S. Slavin, 2001, Bone Marrow Transplantation.

The role of thiotepa in allogeneic stem cell transplantation in patients with leukemia.

A. Nagler, S. Slavin, G. Váradi, 1999, Leukemia research.